Developing adjustment factors to estimate the combined cancer risk of trichlorethylene
On this page:
Introduction
The Integrated Risk Information System (IRIS) assessment for trichloroethylene (TCE) found that human data were sufficient to support dose-response modeling and to develop an inhalation unit risk (IUR) for renal cell carcinoma (RCC). However, human and rodent data suggest that TCE exposure also increases the risk of non-Hodgkin’s lymphoma (NHL) and liver cancer. A combination of two different approaches was used to adjust the IUR to account for potential increased risk of these additional cancer types.
Methods
A factor was developed and applied to the IUR to obtain a combined unit risk estimate (i.e., lifetime extra risk for developing any of the three types of cancer). The adjustment factor to account for the relative contributions to extra risk was calculated from two different data sets: meta-analyses of human epidemiologic data for the three cancer types, and a large cohort study with relative risk (RR) estimates for all three cancer types.
Results
The factor developed accounted for the relative contributions of the three cancer types combined in contrast to the extra risk for RCC alone. The calculations based on two different data sets yielded comparable values for the adjustment factor (both within 25% of the selected factor of 4).
Conclusion
Relative contributions to extra risk were estimated in the absence of dose-response data by calculating an adjustment factor for the additional risk of NHL and liver cancer, in addition to RCC alone. The use of two data sets analyzed by different methods provided more robust support for the use of the factor of 4, based on high-quality epidemiological data.